BSX
Boston Scientific·NYSE
--
--(--)
--
--(--)
5.19 / 10
Netural
Fund flow evaluation: 7.82/10 reflecting robust fund flow characteristics. Constructive overall, block, Large, and Extra-large trends face headwinds from adverse Small and Medium developments, indicating positive money flow direction. The analyst community expresses overwhelmingly bullish analyst consensus with strong conviction. Ratings composition: Strong Buy(47.1%), Buy(52.9%) representing 17 analyst views, supported by 2.55 historical weighted rating.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
47%
Buy
53%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-05
InstitutionMizuho
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for BSX?
- BSX holds a Bearish analyst rating, with 53% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.19/10 (Netural).
